Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

287 trials

NCT07064707
Recruiting
Rupatadine in Patients With Ulcerative Colitis
Phase 2 · Egypt · 1 site
Registry update: 19 Nov 2025
NCT06538402
Recruiting
Ten Versus Fifteen Centimeter Pouch in IPAA Surgery
Not applicable · Denmark · 2 sites
Registry update: 9 Jul 2025
NCT07758335
Recruiting
The Efficacy of Lactobacillous Probiotic and Trace Elements in the Management of Ulcerative Colitis Patients the Patients Will be Recruited From Outpatient Clinic of Inflammatory Bowel Disease (IBD) of the National Hepatology and Tropical Medicine Research Institute NHTMRI, Cairo, Egypt
Phase 4 · Egypt · 1 site
Registry update: 16 Sept 2026
NCT07046468
Recruiting
Smart Pill for Measuring Gut Health in Colon Inflammation and Colon Cancer
Not applicable · Netherlands · 1 site
Registry update: 29 Aug 2025
NCT06937086
Recruiting
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Phase 3 · Austria, Belgium, Bulgaria, Brazil, Canada, Czechia, Germany, Denmark, Spain, France, United Kingdom, Greece, Hungary, Israel, Italy, Mexico, Netherlands, Poland, Puerto Rico, Romania, Slovakia, United States · 185 sites
Registry update: 4 Nov 2026
NCT07113522
Recruiting
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Phase 2 · Canada, Georgia, Moldova, Ukraine, United States · 54 sites
Registry update: 12 Mar 2026
NCT07141238
Recruiting
Microplastic Analysis in Pediatric Inflammatory Bowel Disease
Not applicable · Poland · 1 site
Registry update: 30 Sept 2025
2024-511458-32-00
Recruiting
A study evaluating the effects of filgotinib in children and teenagers with ulcerative colitis
Phase 3 · Belgium, Germany, Spain, France, Greece, Croatia, Ireland, Italy, Norway, Poland, Portugal, Romania · 41 sites
Registry update: 26 Oct 2026
NCT06515210
Recruiting
Personalized Anti-Inflammatory Fibres in Ulcerative Colitis
Not applicable · Canada · 1 site
Registry update: 5 Jun 2026
NCT06850727
Recruiting
Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
Phase 2 · Austria, Australia, Canada, Czechia, Jordan, Lithuania, Moldova, New Zealand, Poland, Ukraine · 32 sites
Registry update: 11 Feb 2026
NCT06993974
Recruiting
Nitazoxanide in Patients With Ulcerative Colitis
Phase 2 · Egypt · 1 site
Registry update: 27 Jun 2025
NCT06764615
Recruiting
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Phase 2 · Belgium, Bulgaria, China, Czechia, Germany, Denmark, France, Greece, Hungary, Italy, South Korea, Netherlands, Norway, Poland, Romania, Slovakia, United States · 97 sites
Registry update: 22 May 2026
2023-506628-98-00
Recruiting
Evaluation of the efficacy and safety of dual biologic and/or small molecule therapy in patients with induction-resistant ulcerative colitis (RESPECT).
Phase 2 · Poland · 5 sites
Registry update: 10 Jul 2026
NCT06420375
Recruiting
Treatment of UC With Novel Therapeutics
Phase 2 · United States · 1 site
Registry update: 21 Jul 2026
NCT07012395
Recruiting
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Phase 2 · Argentina, Austria, Australia, Belgium, Bulgaria, Brazil, Canada, Switzerland, Chile, Czechia, Germany, Spain, France, Georgia, Greece, Croatia, Hungary, Israel, India, Italy, Jordan, Japan, South Korea, Lithuania, Moldova, Mexico, Netherlands, Poland, Romania, Serbia, Slovakia, Taiwan, Ukraine, United States · 296 sites
Registry update: 27 Oct 2026
NCT06896305
Recruiting
Impact of Exclusion Diet in Addition to Anti-TNF Therapy in Crohn's Disease and Ulcerative Colitis: a Prospective, Randomized, Double-arm, Open-label Study
Not applicable · Italy · 1 site
Registry update: 22 Jan 2026
NCT07724990
Recruiting
A Specific Probiotic in thE MOdulation of Gut Microbiota of patieNts With Mild-to-modErate Ulcerative Colitis
Not applicable · Italy · 1 site
Registry update: 27 Jul 2026
NCT06750731
Recruiting
Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
Not applicable · United States · 6 sites
Registry update: 9 Oct 2026
NCT07670975
Recruiting
Resting Energy Expenditure in Pediatric Patients With Inflammatory Bowel Disease (REE-MICI)
Not applicable · Italy · 1 site
Registry update: 26 Jun 2026
NCT06962020
Recruiting
Selection and Efficacy-Influencing Factors of First-Line Biologic Agents in Moderate-to-Severe Ulcerative Colitis
Not applicable · China · 1 site
Registry update: 3 Jul 2025

Ordered by registry start date. Freshness and sponsorship never change the order.